Related Experiment Video
Updated: Nov 11, 2025

09:33
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.2K
G-quadruplexes originating from evolutionary conserved L1 elements interfere with neuronal gene expression in
Roy Hanna1, Anthony Flamier1,2, Andrea Barabino1
1Stem Cell and Developmental Biology Laboratory, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada.
Nature Communications
|March 24, 2021
Summary
Polycomb protein BMI1 influences Guanine-quadruplex (G4) DNA structures in neurons. Reduced BMI1 and relaxed chromatin, seen in Alzheimer's disease (AD), increase G4 accumulation, particularly at active Long Interspersed Element-1 (L1) sequences.
Area of Science:
- Neuroscience
- Genetics
- Epigenetics
Background:
- G-quadruplexes (G4) are stable DNA structures formed by guanine-rich sequences.
- Polycomb group protein BMI1 is crucial for maintaining heterochromatin and gene silencing.
- Altered chromatin states are implicated in neurodegenerative diseases like Alzheimer's disease (AD).
Purpose of the Study:
- To investigate the relationship between BMI1, G4 structures, and chromatin state in neurons.
- To explore the role of G4 structures in Alzheimer's disease pathogenesis.
- To identify the genomic locations and regulatory factors associated with G4 accumulation.
Main Methods:
- Chromatin immunoprecipitation sequencing (ChIP-seq) to map G4 and BMI1 enrichment.
- Analysis of G4 structures in neuronal cells with varying BMI1 expression and chromatin states.
- Correlation analysis between G4 localization, L1 elements, and RNA Polymerase II (RNAPII) occupancy.
Main Results:
- BMI1 is enriched at heterochromatin regions with G4 DNA.
- G4 structures accumulate in cells with reduced BMI1 or relaxed chromatin, notably in AD neurons.
- G4 peaks colocalize with transcriptionally active Long Interspersed Element-1 (L1) sequences and RNAPII.
- Intragenic G4 structures impact splicing and reduce neuronal gene expression in AD.
- Inhibition of transcription reverses G4 accumulation without altering chromatin compaction.
Conclusions:
- BMI1 and chromatin compaction regulate G4 formation in neurons.
- Active L1 elements are a major source of G4 structures in human neurons.
- G4 accumulation in AD neurons is linked to L1 activity, splicing dysregulation, and reduced gene expression.
Related Concept Videos
Alzheimer's Disease: Overview
1.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.0K
Non-LTR Retrotransposons
12.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
12.5K
Alzheimer's Disease: Treatment
539
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
539

